D. C. Brown

ORCID: 0009-0003-0508-1057
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Monoclonal and Polyclonal Antibodies Research
  • Virus-based gene therapy research
  • Acne and Rosacea Treatments and Effects
  • Synthesis and biological activity
  • vaccines and immunoinformatics approaches
  • SARS-CoV-2 and COVID-19 Research
  • Pneumonia and Respiratory Infections
  • Ocular Diseases and Behçet’s Syndrome
  • Viral Infectious Diseases and Gene Expression in Insects
  • Poxvirus research and outbreaks
  • Immunodeficiency and Autoimmune Disorders
  • Herpesvirus Infections and Treatments
  • Respiratory viral infections research

The Graduate Center, CUNY
2023

CUNY Advanced Science Research Center
2023

University of Florida
1971

Tilorone hydrochloride was studied in humans to determine whether it would be a safe and effective interferon inducer man. Both systemic topical application failed produce detectible interferon, toxicity noted using both routes of administration. This study indicates that even the high doses, tilorone HCl is neither nor effective.

10.3181/00379727-137-35576 article EN Experimental Biology and Medicine 1971-05-01

Five cases of secondary and recurrent herpes simplex conjunctivitis without corneal involvement are presented. The disease may vary from an asymptomatic to a severe ulcerative disease. Each case was confirmed by isolation the virus, one patient demonstrated antigen in conjunctival tissue.

10.1001/archopht.1968.03850040735013 article EN Archives of Ophthalmology 1968-06-01

Adenovirus infection of man is common and some adenoviruses have been implicated as causative factors cancer in animals. Some types adenovirus produce sufficiently mild infections, however, so that volunteer studies with these agents appear relatively simple risk free (1,2). The testing drugs on randomly occurring diseases difficult, since a definite clinical diagnosis may not be possible until the disease past. In addition, variability cases, except very large epidemics, would require...

10.3181/00379727-127-32862 article EN Experimental Biology and Medicine 1968-04-01

Despite development of effective SARS-CoV-2 vaccines, a sub-group vaccine non-responders depends on therapeutic antibodies or small-molecule drugs in cases severe disease. However, perpetual viral evolution has required continuous efficacy monitoring as well exploration new antibodies, to circumvent resistance mutations arising the population. We performed SARS-CoV-2-specific B cell sorting and subsequent single-cell sequencing material from 15 convalescent participants. Through screening...

10.1371/journal.pone.0291131 article EN cc-by PLoS ONE 2023-09-20
Coming Soon ...